Abstract:It has been previously reported that vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 are important for the occurrence and development of non-small cell lung cancer (NSCLC). The present study was designed to detect the serum levels of VEGF and MMP-9 in NSCLC, and to explore their diagnostic and prognostic values. A total of 543 cases were involved, of which 332 were NSCLC (272 cases in the pretreatment group and 60 cases in the postoperative group), 91 were patients with benign lung diseases and 120 were healthy controls. The serum levels of VEGF and MMP-9 were determined by Luminex multiplex technology. The serum levels of VEGF and MMP-9 were found to be significantly higher in the pretreatment group than those in the patients with benign lung diseases and healthy controls (VEGF, P<0.0001; MMP-9, P<0.0001). Compared with the pretreatment group, the serum levels of VEGF and MMP-9 in the postoperative group were significantly decreased (VEGF, P=0.005; MMP-9, P=0.002), and the levels of VEGF and MMP-9 in the pretreatment group of patients with stages III and IV were higher than those with stages I and II (VEGF, P<0.0001; MMP-9, P=0.021). In addition, the levels of VEGF and MMP-9 were found to closely correlate with lymph node metastasis (VEGF, P<0.0001; MMP-9, P<0.0001) in the pretreatment group, while being independent of other clinicopathological parameters (P>0.05). Furthermore, a positive correlation was observed between the serum levels of VEGF and MMP-9 (r=0.159; P=0.009). A receiver operating characteristic curve analysis showed that the diagnostic value of MMP-9 was higher than that of VEGF in the pretreatment group. The log-rank test indicated that the inoperable NSCLC patients with low levels of VEGF exhibited a significantly longer overall survival time than those with high VEGF levels (P<0.0001). Additionally, the serum levels of VEGF and lymph node metastasis were identified as independent prognostic factors of the inoperable NSCLC patients in a multivariate Cox regression analysis (P<0.05). These results indicated that VEGF and MMP-9 may be potential biomarkers for the diagnosis and prognosis of NSCLC.

The Expression of VEGF and Endostatin in Serum in Patients with Lung Cancer

[Serum Levels of Endostatin and VEGF in Non-Small Cell Lung Cancer Patients and the Relationship with the Clinical Pathophysiological Characteristics].

Clinical predictive value of serum angiogenic factor in patients with osteosarcoma.

Expression and clinical study of vascular endothelial growth factor and its receptors FLT-1, FLK-1/KDR in non-small cell lung cancer

Expression and Significance of Serum Endostatin in Patients with Primary Lung Cancer

[Value of Serum-Vascular Endothelial Growth Factor in the Differential Diagnosis of Solitary Pulmonary Nodule].

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Expression of VEGF and Its Correlation with Prognosis of Small Cell Lung Cancer

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

[The value of serum endostatin level in early diagnosis of lung cancer]

Clinical significance of serum VEGF in 78 patients with non-small cell lung cancer

Expression of Vascular Endothelial Growth Factor in Lymph Nodes in Stage I Non-small Cell Lung Cancer and Its Clinical Significance

EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND BASIC FIBROBLAST GROWTH FACTOR IN HUMAN NON-SMALL CELL LUNG CANCER AND THEIR CLINICAL SIGNIFICANCE

Serum vascular endothelial growth factor level in patients with lung cancer and breast cancer and its clinical significance

Detection of VEGF in Patients with Colorectal Cancer and Its Clinical Significance

The Clinical Significance of Serum VEGF Level in Gastric Cancer Patients

[Expression of Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-3 and Nm23-H1 in Oral Squamous Cell Carcinoma].

VEGF-C Expression and Clinical Significance in Esophageal Squamous Cell Carcinoma

Expression of Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in Cervical Squamous Cell Carcinoma and Its Clinical Significance

The expression of human antigen R and vascular endothelial growth factor-C and their significance in non-small cell lung cancer]

Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology